Industry: Pharma & Healthcare
Published Date: 2026-01-08
Pages: 110 Pages
Report ld: 5589520
Request Sample
Customized Report
Compound Puqin Capsule Market Size(US$)

CAGR 2026-2032
3.6%
Market Size,2032
USD 23.91
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Compound Puqin Capsule market was valued at US$ 18.68 million in 2025 and is anticipated to reach US$ 23.91 million by 2032, at a CAGR of 3.6% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Compound Puqin Capsule competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Compound Puqin Capsule is a Chinese patent medicine, mainly used to treat sore throat, tonsillitis, oral ulcers and other symptoms caused by damp-heat accumulation and internal toxicity. It combines a variety of Chinese medicinal materials with the effects of clearing away heat and detoxification, relieving swelling and pain, cooling blood and removing blood stasis, and achieves the purpose of relieving symptoms and promoting recovery through comprehensive conditioning of the body.
The North American market for Compound Puqin Capsule is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Compound Puqin Capsule is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Compound Puqin Capsule include Jilin Jurentang Pharmaceutical Co., Ltd., Tonghua Limin Pharmaceutical Co., Ltd., Anhui Jiren Pharmaceutical Co., Ltd., Jiangxi Yintao Pharmaceutical Co., Ltd., Huludao Guodi Pharmaceutical Co., Ltd., Tonghua Xinghua Pharmaceutical Co., Ltd., Suicheng Pharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Compound Puqin Capsule market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Compound Puqin Capsule. The Compound Puqin Capsule market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Compound Puqin Capsule market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Compound Puqin Capsule manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Compound Puqin Capsule manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Compound Puqin Capsule sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Compound Puqin Capsule Market Overview
1.1 Product Definition
1.2 Compound Puqin Capsule by Type
1.2.1 Global Compound Puqin Capsule Market Value by Type: 2025 vs 2032
1.2.2 0.3g Per Tablet
1.2.3 0.24g Per Tablet
1.3 Compound Puqin Capsule by Application
1.3.1 Global Compound Puqin Capsule Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Compound Puqin Capsule Market Size Estimates and Forecasts
1.4.1 Global Compound Puqin Capsule Revenue 2021–2032
1.4.2 Global Compound Puqin Capsule Sales 2021–2032
1.4.3 Global Compound Puqin Capsule Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Compound Puqin Capsule Market Competition by Manufacturers
2.1 Global Compound Puqin Capsule Sales Market Share by Manufacturers (2021–2026)
2.2 Global Compound Puqin Capsule Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Compound Puqin Capsule Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Compound Puqin Capsule, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Compound Puqin Capsule, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Compound Puqin Capsule, Product Types and Applications
2.7 Global Key Manufacturers of Compound Puqin Capsule, Date of Entry into the Industry
2.8 Global Compound Puqin Capsule Market Competitive Situation and Trends
2.8.1 Global Compound Puqin Capsule Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Compound Puqin Capsule Players Market Share by Revenue
2.8.3 Global Compound Puqin Capsule Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Compound Puqin Capsule Market Scenario by Region
3.1 Global Compound Puqin Capsule Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Compound Puqin Capsule Sales by Region: 2021–2032
3.2.1 Global Compound Puqin Capsule Sales by Region: 2021–2026
3.2.2 Global Compound Puqin Capsule Sales by Region: 2027–2032
3.3 Global Compound Puqin Capsule Revenue by Region: 2021–2032
3.3.1 Global Compound Puqin Capsule Revenue by Region: 2021–2026
3.3.2 Global Compound Puqin Capsule Revenue by Region: 2027–2032
3.4 North America Compound Puqin Capsule Market Facts & Figures by Country
3.4.1 North America Compound Puqin Capsule Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Compound Puqin Capsule Sales by Country (2021–2032)
3.4.3 North America Compound Puqin Capsule Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Compound Puqin Capsule Market Facts & Figures by Country
3.5.1 Europe Compound Puqin Capsule Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Compound Puqin Capsule Sales by Country (2021–2032)
3.5.3 Europe Compound Puqin Capsule Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Compound Puqin Capsule Market Facts & Figures by Region
3.6.1 Asia Pacific Compound Puqin Capsule Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Compound Puqin Capsule Sales by Region (2021–2032)
3.6.3 Asia Pacific Compound Puqin Capsule Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Compound Puqin Capsule Market Facts & Figures by Country
3.7.1 Latin America Compound Puqin Capsule Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Compound Puqin Capsule Sales by Country (2021–2032)
3.7.3 Latin America Compound Puqin Capsule Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Compound Puqin Capsule Market Facts & Figures by Country
3.8.1 Middle East and Africa Compound Puqin Capsule Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Compound Puqin Capsule Sales by Country (2021–2032)
3.8.3 Middle East and Africa Compound Puqin Capsule Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Compound Puqin Capsule Sales by Type (2021–2032)
4.1.1 Global Compound Puqin Capsule Sales by Type (2021–2026)
4.1.2 Global Compound Puqin Capsule Sales by Type (2027–2032)
4.1.3 Global Compound Puqin Capsule Sales Market Share by Type (2021–2032)
4.2 Global Compound Puqin Capsule Revenue by Type (2021–2032)
4.2.1 Global Compound Puqin Capsule Revenue by Type (2021–2026)
4.2.2 Global Compound Puqin Capsule Revenue by Type (2027–2032)
4.2.3 Global Compound Puqin Capsule Revenue Market Share by Type (2021–2032)
4.3 Global Compound Puqin Capsule Price by Type (2021–2032)
5 Segment by Application
5.1 Global Compound Puqin Capsule Sales by Application (2021–2032)
5.1.1 Global Compound Puqin Capsule Sales by Application (2021–2026)
5.1.2 Global Compound Puqin Capsule Sales by Application (2027–2032)
5.1.3 Global Compound Puqin Capsule Sales Market Share by Application (2021–2032)
5.2 Global Compound Puqin Capsule Revenue by Application (2021–2032)
5.2.1 Global Compound Puqin Capsule Revenue by Application (2021–2026)
5.2.2 Global Compound Puqin Capsule Revenue by Application (2027–2032)
5.2.3 Global Compound Puqin Capsule Revenue Market Share by Application (2021–2032)
5.3 Global Compound Puqin Capsule Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Jilin Jurentang Pharmaceutical Co., Ltd.
6.1.1 Jilin Jurentang Pharmaceutical Co., Ltd. Company Information
6.1.2 Jilin Jurentang Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Jilin Jurentang Pharmaceutical Co., Ltd. Compound Puqin Capsule Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Jilin Jurentang Pharmaceutical Co., Ltd. Compound Puqin Capsule Product Portfolio
6.1.5 Jilin Jurentang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Tonghua Limin Pharmaceutical Co., Ltd.
6.2.1 Tonghua Limin Pharmaceutical Co., Ltd. Company Information
6.2.2 Tonghua Limin Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Tonghua Limin Pharmaceutical Co., Ltd. Compound Puqin Capsule Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Tonghua Limin Pharmaceutical Co., Ltd. Compound Puqin Capsule Product Portfolio
6.2.5 Tonghua Limin Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Anhui Jiren Pharmaceutical Co., Ltd.
6.3.1 Anhui Jiren Pharmaceutical Co., Ltd. Company Information
6.3.2 Anhui Jiren Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Anhui Jiren Pharmaceutical Co., Ltd. Compound Puqin Capsule Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Anhui Jiren Pharmaceutical Co., Ltd. Compound Puqin Capsule Product Portfolio
6.3.5 Anhui Jiren Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Jiangxi Yintao Pharmaceutical Co., Ltd.
6.4.1 Jiangxi Yintao Pharmaceutical Co., Ltd. Company Information
6.4.2 Jiangxi Yintao Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Jiangxi Yintao Pharmaceutical Co., Ltd. Compound Puqin Capsule Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Jiangxi Yintao Pharmaceutical Co., Ltd. Compound Puqin Capsule Product Portfolio
6.4.5 Jiangxi Yintao Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Huludao Guodi Pharmaceutical Co., Ltd.
6.5.1 Huludao Guodi Pharmaceutical Co., Ltd. Company Information
6.5.2 Huludao Guodi Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Huludao Guodi Pharmaceutical Co., Ltd. Compound Puqin Capsule Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Huludao Guodi Pharmaceutical Co., Ltd. Compound Puqin Capsule Product Portfolio
6.5.5 Huludao Guodi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Tonghua Xinghua Pharmaceutical Co., Ltd.
6.6.1 Tonghua Xinghua Pharmaceutical Co., Ltd. Company Information
6.6.2 Tonghua Xinghua Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Tonghua Xinghua Pharmaceutical Co., Ltd. Compound Puqin Capsule Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Tonghua Xinghua Pharmaceutical Co., Ltd. Compound Puqin Capsule Product Portfolio
6.6.5 Tonghua Xinghua Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Suicheng Pharmaceutical Co., Ltd.
6.7.1 Suicheng Pharmaceutical Co., Ltd. Company Information
6.7.2 Suicheng Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Suicheng Pharmaceutical Co., Ltd. Compound Puqin Capsule Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Suicheng Pharmaceutical Co., Ltd. Compound Puqin Capsule Product Portfolio
6.7.5 Suicheng Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Compound Puqin Capsule Industry Chain Analysis
7.2 Compound Puqin Capsule Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Compound Puqin Capsule Production Mode & Process Analysis
7.4 Compound Puqin Capsule Sales and Marketing
7.4.1 Compound Puqin Capsule Sales Channels
7.4.2 Compound Puqin Capsule Distributors
7.5 Compound Puqin Capsule Customer Analysis
8 Compound Puqin Capsule Market Dynamics
8.1 Compound Puqin Capsule Industry Trends
8.2 Compound Puqin Capsule Market Drivers
8.3 Compound Puqin Capsule Market Challenges
8.4 Compound Puqin Capsule Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Compound Puqin Capsule market is projected to grow from US$ 18.68 million in 2025 to US$ 23.91 million by 2032, at a CAGR of 3.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 137
USD 4900.00
(Single User License)
The global Compound Puqin Capsule market size was US$ 18.68 million in 2025 and is forecast to reach a readjusted size of US$ 23.91 million by 2032 with a CAGR of 3.6% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 79
USD 4250.00
(Single User License)
The global market for Compound Puqin Capsule was estimated to be worth US$ 18.68 million in 2025 and is projected to reach US$ 23.91 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 92
USD 3950.00
(Single User License)
The global Compound Puqin Capsule market is projected to grow from US$ 16.3 million in 2024 to US$ 22.4 million by 2031, at a CAGR of 3.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 134
USD 4900.00
(Single User License)
The global market for Compound Puqin Capsule was estimated to be worth US$ 16.3 million in 2024 and is forecast to a readjusted size of US$ 22.4 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 100
USD 3950.00
(Single User License)
The global Compound Puqin Capsule market size was US$ 16.3 million in 2024 and is forecast to a readjusted size of US$ 22.4 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 78
USD 4250.00
(Single User License)
The global market for Compound Puqin Capsule was valued at US$ 16.3 million in the year 2024 and is projected to reach a revised size of US$ 22.4 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Published Date: 2025-03-13
Pages: 86
USD 2900.00
(Single User License)
The global market for Compound Puqin Capsule was estimated to be worth US$ 16.3 million in 2024 and is forecast to a readjusted size of US$ 22.4 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 104
USD 3950.00
(Single User License)
The global market for Compound Puqin Capsule was estimated to be worth US$ 16.3 million in 2023 and is forecast to a readjusted size of US$ 22.4 million by 2030 with a CAGR of 3.6% during the forecast period 2024-2030.
Published Date: 2025-01-04
Pages: 95
USD 3950.00
(Single User License)
The global market for Compound Puqin Capsule was valued at US$ 16.3 million in the year 2023 and is projected to reach a revised size of US$ 22.4 million by 2030, growing at a CAGR of 3.6% during the forecast period.
Published Date: 2025-01-04
Pages: 78
USD 2900.00
(Single User License)
The global Compound Puqin Capsule market is projected to grow from US$ 18.68 million in 2025 to US$ 23.91 million by 2032, at a CAGR of 3.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 137
The global Compound Puqin Capsule market size was US$ 18.68 million in 2025 and is forecast to reach a readjusted size of US$ 23.91 million by 2032 with a CAGR of 3.6% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 79
The global market for Compound Puqin Capsule was estimated to be worth US$ 18.68 million in 2025 and is projected to reach US$ 23.91 million, growing at a CAGR of 3.6% from 2026 to 2032.
Published: 2026-01-19
Pages: 92
The global Compound Puqin Capsule market is projected to grow from US$ 16.3 million in 2024 to US$ 22.4 million by 2031, at a CAGR of 3.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 134
The global market for Compound Puqin Capsule was estimated to be worth US$ 16.3 million in 2024 and is forecast to a readjusted size of US$ 22.4 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 100
The global Compound Puqin Capsule market size was US$ 16.3 million in 2024 and is forecast to a readjusted size of US$ 22.4 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 78
The global market for Compound Puqin Capsule was valued at US$ 16.3 million in the year 2024 and is projected to reach a revised size of US$ 22.4 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Published: 2025-03-13
Pages: 86
The global market for Compound Puqin Capsule was estimated to be worth US$ 16.3 million in 2024 and is forecast to a readjusted size of US$ 22.4 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 104
The global market for Compound Puqin Capsule was estimated to be worth US$ 16.3 million in 2023 and is forecast to a readjusted size of US$ 22.4 million by 2030 with a CAGR of 3.6% during the forecast period 2024-2030.
Published: 2025-01-04
Pages: 95
The global market for Compound Puqin Capsule was valued at US$ 16.3 million in the year 2023 and is projected to reach a revised size of US$ 22.4 million by 2030, growing at a CAGR of 3.6% during the forecast period.
Published: 2025-01-04
Pages: 78
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now